BiomX (PHGE) Other Accumulated Expenses (2018 - 2025)
BiomX (PHGE) posted Other Accumulated Expenses of $29000.0 for Q1 2025, up 3.57% sequentially from $28000.0 in Q4 2023.
BiomX (PHGE) Other Accumulated Expenses (2018 - 2025) Analysis & Trends
BiomX has reported Other Accumulated Expenses for 7 years, with the latest figure at $29000.0 in Q1 2025.
- Quarterly Other Accumulated Expenses changed N/A year-over-year to $29000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $29000.0 (changed N/A YoY) and the FY2023 annual result came in at $28000.0, down 93.58% from the prior year.
- Other Accumulated Expenses grew to $29000.0 in Q1 2025 per PHGE's latest filing, from $28000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $6.3 million in Q3 2021 and troughed at $28000.0 in Q4 2023.
- A 4-year average of $2.3 million and a median of $436000.0 in 2022 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2021 and 2022: Other Accumulated Expenses sank 98.24% in 2021, then soared 522.86% in 2022.
- Over 4 years, Other Accumulated Expenses stood at $70000.0 in 2021, then jumped by 522.86% to $436000.0 in 2022, then sank by 93.58% to $28000.0 in 2023, then grew by 3.57% to $29000.0 in 2025.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $29000.0, $28000.0, and $436000.0 for Q1 2025, Q4 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BiomX | 351,774.34 | -816,225.66 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 29,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Dec 31, 2022 | 436,000.00 |
| Dec 31, 2021 | 70,000.00 |
| Sep 30, 2021 | 6.32 Mn |
| Jun 30, 2021 | 5.20 Mn |
| Mar 31, 2021 | 4.35 Mn |
| Dec 31, 2020 | 3.98 Mn |
| Sep 30, 2020 | 2.81 Mn |
| Jun 30, 2020 | 1.83 Mn |
| Mar 31, 2020 | 2.38 Mn |
| Dec 31, 2019 | 2.60 Mn |
| Dec 31, 2018 | 1.40 Mn |